AstraZeneca PLC (AZN)
70.84
+0.71
(+1.01%)
USD |
NASDAQ |
Apr 23, 16:00
71.26
+0.42
(+0.59%)
After-Hours: 07:37
AstraZeneca 1 Year Total Returns (Daily): -4.23% for April 23, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 23, 2024 | -4.23% |
April 22, 2024 | -5.19% |
April 19, 2024 | -6.38% |
April 18, 2024 | -6.87% |
April 17, 2024 | -4.87% |
April 16, 2024 | -5.54% |
April 15, 2024 | -4.89% |
April 12, 2024 | -4.49% |
April 11, 2024 | -1.66% |
April 10, 2024 | -3.41% |
April 09, 2024 | -3.35% |
April 08, 2024 | -4.35% |
April 05, 2024 | -4.32% |
April 04, 2024 | -2.03% |
April 03, 2024 | -2.32% |
April 02, 2024 | -1.34% |
April 01, 2024 | -0.97% |
March 28, 2024 | 0.94% |
March 27, 2024 | 1.51% |
March 26, 2024 | -0.17% |
March 25, 2024 | -0.88% |
March 22, 2024 | 1.73% |
March 21, 2024 | 0.99% |
March 20, 2024 | 0.66% |
March 19, 2024 | 2.60% |
Date | Value |
---|---|
March 18, 2024 | 2.58% |
March 15, 2024 | 4.95% |
March 14, 2024 | 5.27% |
March 13, 2024 | 5.97% |
March 12, 2024 | 7.32% |
March 11, 2024 | 7.75% |
March 08, 2024 | 6.00% |
March 07, 2024 | 5.23% |
March 06, 2024 | 3.33% |
March 05, 2024 | 1.60% |
March 04, 2024 | 1.56% |
March 01, 2024 | 1.25% |
February 29, 2024 | 0.61% |
February 28, 2024 | 2.47% |
February 27, 2024 | 1.49% |
February 26, 2024 | 1.53% |
February 23, 2024 | -0.17% |
February 22, 2024 | -3.41% |
February 21, 2024 | -4.47% |
February 20, 2024 | -3.69% |
February 16, 2024 | -3.40% |
February 15, 2024 | -7.91% |
February 14, 2024 | -10.47% |
February 13, 2024 | -10.58% |
February 12, 2024 | -8.94% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-10.58%
Minimum
Feb 13 2024
56.23%
Maximum
Jul 17 2020
15.89%
Average
15.00%
Median
Aug 29 2022
1 Year Total Returns (Daily) Benchmarks
GSK PLC | 16.91% |
Amgen Inc | 15.95% |
Sanofi SA | -12.74% |
Viking Therapeutics Inc | 206.1% |
Fusion Pharmaceuticals Inc | 468.2% |